Furthermore, a frequent single nucleotide polymorphism (SNP) of the CD33 gene (rs12459419) has been associated with an improved EFS and OS in pediatric AML patients undergoing chemotherapy combined with GO. Here, CD33 is linked to acute myeloid leukemia.